TICAM1 and cancer: The expression level of TICAM1 in diverse cancers was analyzed using the pan-cancer data, and the results indicated that TICAM1 was downregulated in some cancers like KICH and LUAD, and upregulated in such cancers as KIRC, STAD, etc. (Fig. 1A) The clinical characteristics of the TARGET cohort are shown in Table 1.